A focus on operational efficiencies and higher government spending raises hope for FTDR, ROCK, NX and ASPN amid challenges.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Aspen Aerogels, Inc. (NYSE:ASPN ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Neal Baranosky - Senior Director of Corporate of Strategy & Finance Donald Young - President and CEO Ricardo Rodriguez - CFO and Treasurer Conference Call Participants George Gianarikas - Canaccord Genuity Colin Rusch - Oppenheimer Eric Stine - Craig-Hallum Capital Chip Moore - ROTH Ryan Pfingst - B. Riley Securities Thomas Curran - Seaport Research Partners Operator Good morning.
Aspen Aerogels (ASPN) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to loss of $0.01 per share a year ago.
Aspen Aerogels (ASPN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
The mean of analysts' price targets for Aspen Aerogels (ASPN) points to a 120.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
Aspen Aerogels, Inc. (NYSE:ASPN ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Neal Baranosky – Senior Director of Corporate of Strategy & Finance Donald R. Young – President and CEO Ricardo C.
Aspen Aerogels (ASPN) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.10 per share. This compares to loss of $0.19 per share a year ago.
Aspen Aerogels (ASPN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is how Aspen Aerogels (ASPN) and Heidelberg Materials AG Unsponsored ADR (HDELY) have performed compared to their sector so far this year.